Edgar Filing: LANTRONIX INC

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2014

o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to ___________.

Commission file number: 1-16027

LANTRONIX, INC.

(Exact name of registrant as specified in its charter)

Delaware	33-0362767
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

167 Technology Drive, Irvine, California

(Address of principal executive offices)

92618

(Zip Code)

(949) 453-3990

(Registrant’s telephone number, including area code)

Not Applicable

_____________________________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o		Accelerated filer o
Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes o No x

As of April 25, 2014, there were 14,692,856 shares of the Registrant’s common stock outstanding.

LANTRONIX, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED

March 31, 2014

INDEX

		Page

PART I.	FINANCIAL INFORMATION	4

Item 1.	Financial Statements	4

	Unaudited Condensed Consolidated Balance Sheets at March 31, 2014 and June 30, 2013	4

	Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended March 31, 2014 and 2013	5

	Unaudited Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2014 and 2013	6

	Notes to Unaudited Condensed Consolidated Financial Statements	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	12

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	20

Item 4.	Controls and Procedures	20

PART II.	OTHER INFORMATION	21

Item 1.	Legal Proceedings	21

Item 1A	Risk Factors	21

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	21

Item 3.	Defaults Upon Senior Securities	21

Item 4.	Mine Safety Disclosures	21

Item 5.	Other Information	21

Item 6.	Exhibits	21

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2014, or the Report, contains forward-looking statements within the meaning of the federal securities laws. These forward-looking statements are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this Report or incorporated by reference into this Report are forward-looking statements. These statements include, among other things, any predictions of earnings, revenues, expenses or other financial items; plans or expectations with respect to our development activities or business strategy; statements concerning industry trends; statements regarding anticipated demand for our products, market acceptance of our products, or future customer and sales developments; statements relating to manufacturing forecasts, including the potential benefits of our contract manufacturers sourcing and supplying raw materials and the significant role of original equipment manufacturers in our business; assumptions regarding the future cost and potential benefits of our research and development efforts; liquidity and cash resources forecasts; statements relating to the impact of pending litigation; statements concerning our future operations, financial condition and prospects; and statements relating to the assumptions underlying any of the foregoing. Throughout this Report, we have attempted to identify forward-looking statements by using words such as “may,” “believe,” “will,” “could,” “project,” “anticipate,” “expect,” “estimate,” “should,” “continue,” “potential,” “plan,” “forecasts,” “goal,” “seek,” “intend,” other forms of these words or similar words or expressions or the negative thereof.

We have based our forward-looking statements on our current expectations and projections about trends affecting our business and industry and other future events. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Forward-looking statements are subject to substantial risks and uncertainties that could cause our results or experiences, or future business, financial condition, results of operations or performance, to differ materially from our historical results or those expressed or implied in any forward-looking statement contained in this Report. Some of the risks and uncertainties that may cause actual results to differ from those expressed or implied in the forward-looking statements are described in “Risk Factors” in Item 1A of this Report, our Annual Report on Form 10-K filed with the Securities and Exchange Commission, or the SEC, on August 29, 2013, or the Form 10-K, as well as in our other filings with the SEC. In addition, actual results may differ as a result of additional risks and uncertainties of which we are currently unaware or which we do not currently view as material to our business. For these reasons, investors are cautioned not to place undue reliance on any forward-looking statements.

You should read this Report in its entirety, together with the Form 10-K, the documents that we file as exhibits to this Report and the documents that we incorporate by reference into this Report, with the understanding that our future results may be materially different from what we currently expect. The forward-looking statements we make speak only as of the date on which they are made. We expressly disclaim any intent or obligation to update any forward-looking statements after the date hereof to conform such statements to actual results or to changes in our opinions or expectations, except as required by applicable law or the rules of The Nasdaq Stock Market, LLC. If we do update or correct any forward-looking statements, investors should not conclude that we will make additional updates or corrections.

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

LANTRONIX, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

	March 31,			June 30,
	2014			2013
Assets
Current assets:
Cash and cash equivalents	$	5,877		$	5,243
Accounts receivable, net		3,887			2,599
Contract manufacturers' receivable		566			607
Inventories, net		7,601			8,741
Prepaid expenses and other current assets		470			431
Total current assets		18,401			17,621
Property and equipment, net		1,411			1,687
Goodwill		9,488			9,488
Deferred tax assets		476			476
Other assets		117			87
Total assets	$	29,893		$	29,359

Liabilities and stockholders' equity
Current liabilities:
Accounts payable	$	4,052		$	2,870
Accrued payroll and related expenses		1,872			1,516
Warranty reserve		157			193
Short-term debt		–			167
Deferred tax liabilities		476			476
Other current liabilities		3,105			3,877
Total current liabilities		9,662			9,099
Long-term capital lease obligations		17			54
Other non-current liabilities		161			249
Total liabilities		9,840			9,402

Commitments and contingencies

Stockholders' equity:
Common stock		1			1
Additional paid-in capital		204,687			203,871
Accumulated deficit		(185,006	)		(184,286	)
Accumulated other comprehensive income		371			371
Total stockholders' equity		20,053			19,957
Total liabilities and stockholders' equity	$	29,893		$	29,359

See accompanying notes.

LANTRONIX, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share data)

	Three Months Ended						Nine Months Ended
	March 31,						March 31,
	2014			2013			2014			2013
Net revenue (1)	$	11,593		$	12,164		$	33,444		$	35,528
Cost of revenue		5,694			6,547			16,718			18,407
Gross profit		5,899			5,617			16,726			17,121
Operating expenses:
Selling, general and administrative		4,248			4,685			12,258			13,672
Research and development		1,757			1,717			5,081			4,991
Total operating expenses		6,005			6,402			17,339			18,663
Loss from operations		(106	)		(785	)		(613	)		(1,542	)
Interest expense, net		(6	)		(14	)		(22	)		(45	)
Other income (expense), net		(2	)		10			(30	)		(8	)
Loss before income taxes		(114	)		(789	)		(665	)		(1,595	)
Provision for income taxes		16			12			55			48
Net loss and comprehensive loss	$	(130	)	$	(801	)	$	(720	)	$	(1,643	)

Net loss per share (basic and diluted)	$	(0.01	)	$	(0.05	)	$	(0.05	)	$	(0.11	)

Weighted-average common shares (basic and diluted)		14,686			14,580			14,629			14,572

Net revenue from related parties	$	79		$	221		$	452		$	894

(1) Includes net revenue from related parties

See accompanying notes.

LANTRONIX, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

	Nine Months Ended
	March 31,
	2014			2013
Operating activities
Net loss	$	(720	)	$	(1,643	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Share-based compensation		662			640
Depreciation		693			629
Provision for excess and obsolete inventories		111			163
Gain on reversal of foreign currency translation		–			(28	)
Changes in operating assets and liabilities:
Accounts receivable		(1,288	)		(134	)
Contract manufacturers' receivable		41			93
Inventories		1,029			(3,385	)
Prepaid expenses and other current assets		(39	)		112
Other assets		(30	)		6
Accounts payable		1,182			592
Accrued payroll and related expenses		356			(520	)
Warranty reserve		(36	)		(6	)
Other liabilities		(862	)		365
Net cash provided by (used in) operating activities		1,099			(3,116	)
Investing activities
Purchases of property and equipment		(417	)		(507	)
Net cash used in investing activities		(417	)		(507	)
Financing activities
Payment of term loan		(167	)		(501	)
Proceeds from issuance of common stock		154			–
Minimum tax withholding paid on behalf of employees for restricted shares		–			(26	)
Payment of capital lease obligations		(35	)		(70	)
Net cash used in financing activities		(48	)		(597	)
Increase (decrease) in cash and cash equivalents		634			(4,220	)
Cash and cash equivalents at beginning of period		5,243			11,374
Cash and cash equivalents at end of period	$	5,877		$	7,154

See accompanying notes.

LANTRONIX, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2014

1.	Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of Lantronix, Inc. (referred to in these unaudited condensed consolidated financial statements as “Lantronix,” “we,” “us,” or “our”) have been prepared in accordance with United States generally accepted accounting principles (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Securities and Exchange Commission (“SEC”) Regulation S-X. Accordingly, they should be read in conjunction with the audited consolidated financial statements and notes thereto for the fiscal year ended June 30, 2013, included in our Annual Report on Form 10-K filed with the SEC on August 29, 2013. The unaudited condensed consolidated financial statements contain all normal recurring accruals and adjustments that in the opinion of management, are necessary to present fairly the consolidated financial position of Lantronix at March 31, 2014, and the consolidated results of our operations for the three and nine months ended March 31, 2014 and the consolidated cash flows for the nine months ended March 31, 2014. All intercompany accounts and transactions have been eliminated. It should be understood that accounting measurements at interim dates inherently involve greater reliance on estimates than at year-end. The results of operations for the three and nine months ended March 31, 2014 are not necessarily indicative of the results to be expected for the full year or any future interim periods.

Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board issued guidance requiring a liability related to an unrecognized tax benefit to be offset against a deferred tax asset for a net operating loss carryforward, a similar tax loss or a tax credit carryforward if such settlement is required or expected in the event the uncertain tax position is disallowed. The presentation of unrecognized tax benefits as a reduction of a deferred tax asset is consistent with an entity’s analysis of the realizability of its deferred tax assets and, as a result, is not expected to change an entity’s assessment of realizability. For public companies, this guidance is effective on a prospective basis for fiscal years, and interim periods within those years, beginning after December 15, 2013. Early adoption is permitted. We adopted this guidance for the fiscal year beginning July 1, 2013. Such adoption did not have a material impact on our financial statements.

2.	Supplemental Financial Information

Inventories

Inventories are stated at the lower of cost (first-in, first-out) or market and consist of the following:

	March 31,		June 30,
	2014		2013
	(In thousands)
Finished goods	$	4,396	$	5,107
Raw materials		1,701		2,129
Finished goods held by distributors		1,146		1,429
Large scale integration chips *		358		76
Inventories, net	$	7,601	$	8,741

* This item is sold individually and is also embedded into our products.

Other Liabilities

The following table presents details of our other liabilities:

	March 31,		June 30,
	2014		2013
	(In thousands)
Current
Customer deposits and refunds	$	507	$	1,042
Accrued raw materials purchases		992		1,382
Deferred revenue		129		138
Capital lease obligations		49		47
Taxes payable		236		229
Other accrued liabilities		1,192		1,039
Total other current liabilities	$	3,105	$	3,877

Non-current
Deferred rent	$	63	$	128
Deferred revenue		98		121
Total other non-current liabilities	$	161	$	249

Computation of Net Loss per Share

Basic and diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the applicable period.

The following table presents the computation of net loss per share:

	Three Months Ended						Nine Months Ended
	March 31,						March 31,
	2014			2013			2014			2013
	(In thousands, except per share data)
Numerator:
Net loss	$	(130	)	$	(801	)	$	(720	)	$	(1,643	)
Denominator:
Weighted-average shares outstanding (basic and diluted)		14,686			14,580			14,629			14,572

Net loss per share (basic and diluted)	$	(0.01	)	$	(0.05	)	$	(0.05	)	$	(0.11	)

The following table presents the common stock equivalents excluded from the diluted net loss per share calculation, because they were anti-dilutive for the periods presented. These excluded common stock equivalents could be dilutive in the future.

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2014		2013		2014		2013
	(In thousands)
Common stock equivalents		930		1,537		1,696		1,895

Related Party Transactions

We have historically reported net revenues from two of our international customers, Lynx and Barix AG, as related party transactions due to common ownership by our largest stockholder and Lantronix director, Bernhard Bruscha. Beginning on February 1, 2014, we no longer sell our products directly to Lynx, and therefore, as of this date, our net revenue from related parties only includes net revenues from Barix AG.

Supplemental Cash Flow Information

The following table presents non-cash investing and financing transactions excluded from the unaudited condensed consolidated statement of cash flows:

	Nine Months Ended
	March 31,
	2014		2013
	(In thousands)
Non-cash acquisition of property and equipment under capital leases	$	–	$	68
Accrued property and equipment paid for in the subsequent period	$	–	$	200

3.	Warranty Reserve

The warranty periods for our products generally range from one to five years. We establish reserves for estimated product warranty costs at the time revenue is recognized based upon our historical warranty experience, and additionally, for any known product warranty issues. Although we engage in product quality programs and processes, our warranty obligation is affected by product failure rates, use of materials or service delivery costs that differ from our estimates. As a result, increases or decreases to warranty reserves could be required, which could impact our gross margins.

The following table presents details of our warranty reserve:

	Nine Months Ended March 31,			Year Ended June 30,
	2014			2013
	(In thousands)
Beginning balance	$	193		$	232
Charged to cost of revenues		34			91
Usage		(70	)		(130	)
Ending balance	$	157		$	193

4.	Bank Line of Credit and Debt

We have in effect loan agreements with Silicon Valley Bank (“SVB”), which we collectively refer to herein as the “SVB Loan Agreements.” The SVB Loan Agreements provide for (i) a revolving line of credit that in the aggregate may not exceed $4.0 million and (ii) a $2.0 million term loan, which was completely paid off in September 2013.

The available borrowing capacity under the revolving line of credit is limited to the lesser of (i) $4.0 million or (ii) the current portion of the trade receivable balance, less 50% of the balance of deferred revenue, less outstanding borrowings on the revolving line of credit. As of March 31, 2014, there were no borrowings outstanding on the revolving line of credit.

The SVB Loan Agreements provide for an interest rate per annum equal to the greater of the prime rate plus 0.75% or 4.0%, provided that we maintain a monthly quick ratio of 1.0 to 1.0 or greater. The quick ratio measures our ability to use our cash and cash equivalents maintained at SVB to extinguish or retire our current liabilities immediately. If this ratio is not met, the interest rate will become the greater of the prime rate plus 1.25% or 4.0%. We maintained a monthly quick ratio greater than 1.0 to 1.0 as of and during the nine months ended March 31, 2014.

The SVB Loan Agreements include a covenant requiring us to maintain a certain Minimum Tangible Net Worth (“Minimum TNW”), which is currently $6.0 million. This amount is subject to adjustment upward to the extent we raise additional equity or debt financing or achieve net income in future quarters. Our Actual Tangible Net Worth (“Actual TNW”) is calculated as total shareholders’ equity, less goodwill. If we continue to incur net losses, we may have difficulty satisfying the Minimum TNW financial covenant in the future.

The following table sets forth the Minimum TNW compared to our Actual TNW:

	March 31, 2014
	(In thousands)
Minimum TNW	$	6,000
Actual TNW	$	10,565

The following table presents the available borrowing capacity on the revolving line of credit and outstanding letters of credit, which were used as security deposits. To date, we have not used any of the borrowing capacity under the revolving line of credit.

	March 31,		June 30,
	2014		2013
	(In thousands)
Available borrowing capacity under the revolving line	$	1,656	$	2,187
Outstanding letters of credit	$	113	$	113

5.	Stockholders’ Equity

Share-Based Plans

Our share-based plans permit the granting of stock options (both incentive and nonqualified stock options), stock appreciation rights, non-vested stock, restricted stock units, and performance shares to certain employees, directors and consultants. As of March 31, 2014, no stock appreciation rights, non-vested stock, or performance shares were outstanding.

Stock Option Awards

The following table presents a summary of stock option activity under all of our stock option plans during the nine months ended March 31, 2014:

	Number of Shares			Weighted Average Exercise Price per Share
	(In thousands)
Balance of options outstanding at June 30, 2013		2,305		$	2.63
Options granted		682			1.56
Options forfeited		(69	)		1.95
Options expired		(157	)		3.38
Options exercised		(33	)		1.60
Balance of options outstanding at March 31, 2014		2,728		$	2.35

Restricted Stock Units

In October 2013, we granted to certain employees approximately 61,000 restricted stock units (“RSUs”). Such RSUs vest in their entirety on the one year anniversary of the grant date.

The following table presents a summary of activity with respect to RSUs during the nine months ended March 31, 2014:

	Number of Shares		Weighted Average Grant - Date Fair Value per Share
	(In thousands)
Balance of restricted stock units at June 30, 2013		–	$	–
Restricted stock units granted		61		1.40
Restricted stock units cancelled		–		–
Restricted stock units vested		–		–
Balance of restricted stock units at March 31, 2014		61	$	1.40

Employee Stock Purchase Plan

Our 2013 Employee Stock Purchase Plan (the “ESPP”) is intended to provide employees with an opportunity to purchase our common stock through accumulated payroll deductions. Each of our employees (including officers) is eligible to participate in the ESPP, subject to certain limitations as defined in the ESPP plan document. We have reserved 1,300,000 shares of our common stock for future issuance under the ESPP.

The following table presents a summary of activity under our ESPP during the nine months ended March 31, 2014:

	Nine Months Ended March 31, 2014
	(In thousands)
Shares available for issuance at June 30, 2013		1,300
Shares reserved for issuance		–
Shares issued		(80	)
Shares available for issuance at March 31, 2014		1,220

The first purchase and issuance of shares under the ESPP occurred on November 15, 2013. In accordance with the terms of our ESPP, the exercise price was adjusted to $1.27 per share, which represents 85% of the closing market price of our common stock on November 15, 2013.

Share-Based Compensation Expense

The following table presents a summary of share-based compensation expense included in each functional line item on our unaudited condensed consolidated statements of operations:

	Three Months Ended				Nine Months Ended
	March 31,				March 31,
	2014		2013		2014		2013
	(In thousands)
Cost of revenues	$	11	$	12	$	35	$	33
Selling, general and administrative		144		138		461		425
Research and development		54		53		166		182
Total share-based compensation expense	$	209	$	203	$	662	$	640

The following table summarizes the remaining unrecognized share-based compensation expense related to our outstanding share-based awards as of March 31, 2014:

	Remaining Unrecognized Compensation Cost		Remaining Weighted Average Years To Recognize
	(In thousands)
Stock options	$	1,387		2.5
Restricted stock units		50		0.6
Stock purchase rights under ESPP		139		1.7

If there are any modifications or cancellations of the underlying unvested share-based awards, we may be required to accelerate, increase or cancel remaining unearned share-based compensation expense. Future share-based compensation expense and unearned share-based compensation will increase to the extent that we grant additional share-based awards.

6.	Income Taxes

We utilize the liability method of accounting for income taxes. The following table presents our effective tax rates based upon the income tax provision for the periods shown:

	Three Months Ended March 31,						Nine Months Ended March 31,
	2014			2013			2014			2013
Effective tax rate		14	%		2	%		8	%		3	%

The difference between our effective tax rates in the periods presented above and the federal statutory rate is primarily due to a tax benefit from our domestic losses being recorded with a full valuation allowance, as well as the effect of foreign earnings taxed at rates differing from the federal statutory rate.

We record net deferred tax assets to the extent that we believe these assets will more likely than not be realized. As a result of our cumulative losses and uncertainty of generating future taxable income, we have provided a full valuation allowance against our net deferred tax assets as of March 31, 2014 and June 30, 2013.

7.	Litigation and Contingencies

From time to time, we are subject to legal proceedings and claims in the ordinary course of business. We are not currently aware of any such legal proceedings or claims that are expected to have, individually or in the aggregate, a material adverse effect on our business, prospects, financial position, operating results or cash flows.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis in conjunction with our consolidated financial statements and related notes included in Item 1 of this Report, the “Risk Factors” included in Item 1A of this Report and in our Annual Report on Form 10-K for the year ended June 30, 2013, as well as the Cautionary Note Regarding Forward Looking Statements described elsewhere in this Report, before deciding to purchase, hold or sell our common stock.

Overview

Lantronix, Inc. (the “Company,” “Lantronix,” “we,” “our,” or “us”) designs, develops, markets and sells networking and communications products with a focus on the convergence of mobility with machine-to-machine (“M2M”) systems. We provide solutions that enable machines, devices and sensors to be securely accessed, managed and controlled. Our solutions are designed to make it easier and more cost effective for our customers to participate in the Internet of Things (“IoT”) market.

We provide a broad portfolio of products intended to enhance the value of electronic devices or machines. Our products are typically used by enterprise and commercial businesses, government institutions, telecommunication and utility companies, financial institutions, medical institutions, and individual consumers.

We organize our solutions into two product lines based on how they are marketed, sold and deployed: OEM Modules and Enterprise Solutions. We conduct our business globally and manage our sales teams by geography, according to four regions: the Americas; Europe, Middle East, and Africa (“EMEA”); Asia Pacific; and Japan.

Products and Solutions Overview

OEM Modules

OEM Modules are electronic products that serve as building blocks embedded inside modern electronic systems and equipment. Our OEM Modules product line includes wired and wireless products that are designed to enhance the value and utility of modern electronic systems and equipment by providing secure network connectivity, application hosting, protocol conversion and other functions.

The products are offered with a software suite intended to decrease our customer’s time-to-market and increase their value add. Among others, the following product families are included in our OEM Module product line: MatchPort®, PremiereWave® EN, WiPort®, xPico®, xPico®Wi-Fi, and xPort®.

OEM Modules are typically sold to OEMs, original design manufacturers (“ODMs”), contract manufacturers and distributors. OEMs design and sell products under their own brand that are either manufactured by the OEM in-house or by third-party contract manufacturers. ODMs design and manufacture products for third parties, which then sell those products under their own brand. The design cycles typically range from 12 to 24 months and can generate recurring revenue for the entire life-cycle of an end-user’s product.

Enterprise Solutions

Our Enterprise Solutions are electronic products that are typically connected to one or more existing pieces of electronic equipment to provide additional connectivity or functionality. Our Enterprise Solutions are designed to enhance the value and utility of machines and other devices though network connectivity, routing, switching, application hosting, remote management, telemetry, telematics, printing, protocol conversion and other functions. Enterprise Solutions includes products such as wired and wireless device servers, I/O servers, terminal servers, console servers, print servers, remote keyboard video mouse (KVM), power management and software management platforms. Among others, the following product families are included in our Enterprise Solution product line: EDS, PremierWave® XC, PremierWave® XN, SLB™, SLC™, SLP™, Spider™, UDS, xDirect®, xPress™, xPrintServer®, and xSenso®.

Enterprise Solutions are typically sold though value added retailers (“VARs”), systems integrators, distributors, e-tailers and to a lesser extent to OEMs. Sales are often project based which may result in significant quarterly fluctuations.

Recent Accounting Pronouncements

Please refer to Note 1 of Notes to Unaudited Condensed Consolidated Financial Statements, included in Part I, Item 1 of this Report for a discussion of recent accounting pronouncements.

Critical Accounting Policies and Estimates

The accounting policies that have the greatest impact on our financial condition and results of operations and that require the most judgment are those relating to revenue recognition, warranty reserves, allowance for doubtful accounts, inventory valuation, valuation of deferred income taxes, and goodwill. These policies are described in further detail in our Annual Report on Form 10-K for the fiscal year ended June 30, 2013. There have been no significant changes in our critical accounting policies and estimates during the three and nine months ended March 31, 2014 as compared to what was previously disclosed in our Annual Report on Form 10-K for the fiscal year ended June 30, 2013.

Results of Operations - Summary

In the three months ended March 31, 2014 our net loss was $130,000 compared to a net loss of $801,000 in the three months ended March 31, 2013. The decrease in net loss was impacted by (i) an increase in gross margin from 46.2% to 50.9% and (ii) a decrease in selling, general and administrative expenses of $437,000, or 9.3%, primarily as result of lower marketing-related costs. The gross margin improvement and cost reduction were partially offset by a decline in net revenue of approximately $571,000 or 4.7%, for the three months ended March 31, 2014, as compared to the three months ended March 31, 2013.

In the nine months ended March 31, 2014 our net loss was $720,000 compared to a net loss of $1.6 million in the nine months ended March 31, 2013. The decrease in net loss was impacted by a decrease in selling, general and administrative expenses of $1.4 million, or 10.3%, primarily as a result of lower marketing-related costs, along with cost-reduction efforts which resulted in decreases in professional fees and personnel-related costs. In addition, our gross profit as a percentage of revenue for the nine months ended March 31, 2014 increased to 50.0% from 48.2% for the nine months ended March 31, 2013. The cost reductions and improvement in gross profit as a percentage of net revenue were partially offset by a decline in net revenue of approximately $2.1 million, or 5.9%, for the nine months ended March 31, 2014, as compared to the nine months ended March 31, 2013.

Results of Operations – Three Months Ended March 31, 2014 Compared to the Three Months Ended March 31, 2013

Net Revenue by Product Line and Geographic Region

The following tables present our fiscal quarter net revenue by product line and geographic region:

	Three Months Ended March 31,
			% of Net					% of Net			Change
	2014		Revenue			2013		Revenue			$			%
	(In thousands, except percentages)
OEM Modules	$	6,091		52.5	%	$	6,321		52.0	%	$	(230	)		(3.6	%)
Enterprise Solutions		5,502		47.5	%		5,843		48.0	%		(341	)		(5.8	%)
Net revenue	$	11,593		100.0	%	$	12,164		100.0	%	$	(571	)		(4.7	%)

	Three Months Ended March 31,
	2014						2013
	(In thousands)
		OEM Modules		Enterprise Solutions		Total		OEM Modules		Enterprise Solutions		Total
Americas	$	2,409	$	3,475	$	5,884	$	2,371	$	4,130	$	6,501
EMEA		2,241		1,455		3,696		2,376		1,230		3,606
Asia Pacific		665		319		984		646		218		864
Japan		776		253		1,029		928		265		1,193
	$	6,091	$	5,502	$	11,593	$	6,321	$	5,843	$	12,164

OEM Modules

Based on our experience, OEM Module products typically have a range of 12 to 24 months prior to reaching a meaningful revenue level. To date, the revenue contribution from our newer OEM Modules products has been modest. Revenue from our OEM Modules product line decreased due to a general decline in unit sales across our mature OEM Modules products. In the Americas region, the decrease in mature OEM Modules was partially offset by increased unit sales of the xPico, a new product family,as a result of a new customer design win moving into production.

Enterprise Solutions

The decrease in net revenue from our Enterprise Solutions product line was primarily due to decreases in unit sales of our xPrinterServer product family, largely in the Americas region. In addition, our Enterprise Solutions business was negatively impacted by lower distribution sales in the Americas region. In part, the decrease was offset by increased Enterprise Solutions sales in the EMEA and Asia Pacific regions, where we have expanded our sales and distribution channels over the past year.

Gross Profit

Gross profit represents net revenue less cost of revenue. Cost of revenue consists primarily of the cost of raw material components, subcontract labor assembly from contract manufacturers, manufacturing overhead, establishing or relieving inventory reserves for excess and obsolete products or raw materials, warranty costs, royalties and share-based compensation.

The following table presents our fiscal quarter gross profit:

	Three Months Ended March 31,
			% of Net					% of Net			Change
	2014		Revenue			2013		Revenue			$		%
	(In thousands, except percentages)
Gross profit	$	5,899		50.9	%	$	5,617		46.2	%	$	282		5.0	%

Gross profit as a percent of revenue (referred to as “gross margin”) for the three months ended March 31, 2014 was higher than the prior year period due to lower materials costs and a reduction in sales discounts. In the current quarter we also experienced a reduction in costs related to inventory reserves as compared to the prior year quarter.

As newer products typically have lower margins until they reach production volumes, we may experience downward pressure on gross margins as new product revenues grow as a percentage of total net revenue.

Selling, General and Administrative

Selling, general and administrative expenses consist of personnel-related expenses, including salaries and commissions, share-based compensation, facility expenses, information technology, trade show expenses, advertising, and legal and accounting fees.

The following table presents our fiscal quarter selling, general and administrative expenses:

	Three Months Ended March 31,
			% of Net						% of Net			Change
	2014		Revenue			2013			Revenue			$			%
	(In thousands, except percentages)
Personnel-related expenses	$	2,633				$	2,656					$	(23	)		(0.9	%)
Professional fees and outside services		284					341						(57	)		(16.7	%)
Advertising and marketing		571					919						(348	)		(37.9	%)
Facilities		262					256						6			2.3	%
Travel		149					203						(54	)		(26.6	%)
Share-based compensation		144					138						6			4.3	%
Depreciation		83					99						(16	)		(16.2	%)
Bad debt expense (recovery)		22					(5	)					27			(540.0	%)
Other		100					78						22			28.2	%
Selling, general and administrative	$	4,248		36.6	%	$	4,685			38.5	%	$	(437	)		(9.3	%)

The decrease in selling, general and administrative expenses was primarily due to (i) a decrease in advertising and marketing fees, as such spending in the prior year quarter was significantly higher as we focused on marketing initiatives for certain new product releases and (ii) decreased legal and other professional fees.

Research and Development

Research and development expenses consist of personnel-related expenses, including share-based compensation, as well as expenditures to third-party vendors for research and development activities and product certification costs.

The following table presents our fiscal quarter research and development expenses:

	Three Months Ended March 31,
			% of Net					% of Net			Change
	2014		Revenue			2013		Revenue			$			%
	(In thousands, except percentages)
Personnel-related expenses	$	1,120				$	1,136				$	(16	)		(1.4	%)
Facilities		177					190					(13	)		(6.8	%)
Outside services		201					180					21			11.7	%
Product certifications		91					111					(20	)		(18.0	%)
Share-based compensation		54					53					1			1.9	%
Other		114					47					67			142.6	%
Research and development	$	1,757		15.2	%	$	1,717		14.1	%	$	40			2.3	%

Research and development expenses during the current quarter remained relatively consistent with the prior year period. Expenses were impacted by increased materials expenses related to new product development.

Results of Operations – Nine Months Ended March 31, 2014 Compared to the Nine Months Ended March 31, 2013

Net Revenue by Product Line and Geographic Region

The following tables present fiscal year-to-date net revenue by product line and geographic region:

	Nine Months Ended March 31,
			% of Net					% of Net			Change
	2014		Revenue			2013		Revenue			$			%
	(In thousands, except percentages)
OEM Modules	$	16,005		47.9	%	$	17,655		49.7	%	$	(1,650	)		(9.3	%)
Enterprise Solutions		17,439		52.1	%		17,873		50.3	%		(434	)		(2.4	%)
Net revenue	$	33,444		100.0	%	$	35,528		100.0	%	$	(2,084	)		(5.9	%)

	Nine Months Ended March 31,
	2014						2013
	(In thousands)
	OEM Modules		Enterprise Solutions		Total		OEM Modules		Enterprise Solutions		Total
Americas	$	6,005	$	11,465	$	17,470	$	6,652	$	12,657	$	19,309
EMEA		6,184		3,855		10,039		6,668		3,590		10,258
Asia Pacific		1,924		1,151		3,075		1,844		994		2,838
Japan		1,892		968		2,860		2,491		632		3,123
	$	16,005	$	17,439	$	33,444	$	17,655	$	17,873	$	35,528

OEM Modules

Based on our experience, OEM Module products typically have a range of 12 to 24 months prior to reaching a meaningful revenue level. To date, the revenue contribution from our new OEM Modules products has been modest. Revenue from our OEM Modules product line decreased due to declining unit sales across our mature OEM Modules products in all regions. The overall decline in OEM Module revenue was partially offset by increased unit sales of the xPico, a new product family, primarily in the Americas region.

Enterprise Solutions

The decrease in net revenue from our Enterprise Solutions product line was primarily due to decreases in unit sales of our xPrinterServer and UDS product families in the Americas. In addition, our Enterprise Solutions business was negatively impacted by lower distribution sales in the Americas region. The decrease in the Americas region was partially offset by increased unit sales in two of our new product families, Premierwave XN and SLB primarily as a result of project wins at two Tier One customers. In addition, the decrease in the Americas region was partially offset by increased net revenue in EMEA, Japan and Asia Pacific regions as a result of our efforts to expand our Enterprise Solutions sales channels in these regions.

Gross Profit

The following table presents fiscal year-to-date gross profit:

	Nine Months Ended March 31,
			% of Net					% of Net			Change
	2014		Revenue			2013		Revenue			$			%
	(In thousands, except percentages)
Gross profit	$	16,726		50.0	%	$	17,121		48.2	%	$	(395	)		(2.3	%)

Gross margin for the nine months ended March 31, 2014 increased compared the prior year period primarily due to lower materials cost, along with lower manufacturing and freight costs and favorable product mix.

Selling, General and Administrative

The following table presents fiscal year-to-date selling, general and administrative expenses:

	Nine Months Ended March 31,
				% of Net					% of Net			Change
	2014			Revenue			2013		Revenue			$			%
	(In thousands, except percentages)
Personnel-related expenses	$	7,452					$	7,753				$	(301	)		(3.9	%)
Professional fees & outside services		1,053						1,358					(305	)		(22.5	%)
Advertising and marketing		1,430						2,132					(702	)		(32.9	%)
Facilities		812						793					19			2.4	%
Travel		461						527					(66	)		(12.5	%)
Share-based compensation		461						425					36			8.5	%
Depreciation		286						326					(40	)		(12.3	%)
Bad debt expense (recovery)		(41	)					37					(78	)		(210.8	%)
Other		344						321					23			7.2	%
Selling, general and administrative	$	12,258			36.7	%	$	13,672		38.5	%	$	(1,414	)		(10.3	%)

The decrease in selling, general and administrative expenses was primarily due to a decrease in advertising and marketing fees from the prior year period when we increased spending on marketing initiatives for certain new product releases. We also saw lower sales-related commission expenses in the current year period due to the lower net revenues. Also, we further reduced expenses through cost cutting efforts near the end of our fiscal year ended June 30, 2013 which lowered personnel-related expenses along with accounting and legal fees.

Research and Development

The following table presents fiscal year-to-date research and development expenses:

	Nine Months Ended March 31,
			% of Net					% of Net			Change
	2014		Revenue			2013		Revenue			$			%
	(In thousands, except percentages)
Personnel-related expenses	$	3,378				$	3,260				$	118			3.6	%
Facilities		557					643					(86	)		(13.4	%)
Outside Services		581					559					22			3.9	%
Product certifications		173					217					(44	)		(20.3	%)
Share-based compensation		166					182					(16	)		(8.8	%)
Other		226					130					96			73.8	%
Research and development	$	5,081		15.2	%	$	4,991		14.0	%	$	90			1.8	%

Research and development expenses were impacted by (i) increased personnel-related expenses in the current year period primarily related to increased variable compensation and (ii) increased materials expenses related to new product development.

These increases were partially offset by (i) lower facilities costs and (ii) decreased product certification costs due to the timing of development projects.

Results of Operations - Provision for Income Taxes

The following table presents our effective tax rate based upon our income tax provision:

	Three Months Ended						Nine Months Ended
	March 31,						March 31,
	2014			2013			2014			2013
Effective tax rate		14	%		2	%		8	%		3	%

We utilize the liability method of accounting for income taxes. The difference between our effective tax rates and the federal statutory rate resulted primarily from a tax benefit from our domestic losses being recorded with a full valuation allowance, as well as the effect of foreign earnings taxed at rates differing from the federal statutory rate.

Liquidity and Capital Resources

The following table presents information about our working capital and cash:

	March 31,		June 30,
	2014		2013
	(In thousands)
Working capital	$	8,739	$	8,522
Cash and cash equivalents	$	5,877	$	5,243

Our principal sources of cash and liquidity include our existing cash and cash equivalents, amounts available under our credit facilities and cash from operations. We believe that these sources are sufficient to fund the current requirements of working capital, capital expenditures and other financial commitments for at least the next 12 months. The primary drivers affecting cash and liquidity are net revenue, working capital requirements, and capital expenditures.

Management defines cash and cash equivalents as highly liquid deposits with original maturities of 90 days or less when purchased. We maintain cash and cash equivalents balances at certain financial institutions in excess of amounts insured by federal agencies. Management does not believe this concentration subjects us to any unusual financial risk beyond the normal risk associated with commercial banking relationships. We frequently monitor the third-party depository institutions that hold our cash and cash equivalents. Our emphasis is primarily on safety of principal and secondarily on maximizing yield on those funds.

Our future working capital requirements will depend on many factors, including the timing and amount of our net revenue, research and development expenses, and expenses associated with any strategic partnerships or acquisitions and infrastructure investments. From time to time, we may seek additional capital from public or private offerings of our capital stock, borrowings under our existing or future credit lines or other sources in order to (i) develop or enhance our products, (ii) take advantage of future opportunities, (iii) respond to competition or (iv) continue to operate our business. If we issue equity or debt securities to raise additional funds, our existing stockholders may experience dilution, and the new equity or debt securities may have rights, preferences and privileges senior to those of our existing stockholders. There can be no assurance that we will be able to raise any such capital on terms acceptable to us, if at all.

Loan Agreement

	March 31,		June 30,
	2014		2013
	(In thousands)
Available borrowing capacity under the revolving line	$	1,656	$	2,187
Outstanding letters of credit	$	113	$	113

The following table sets forth the Minimum TNW compared to our Actual TNW:

	December 31, 2013
	(In thousands)
Minimum TNW	$	6,000
Actual TNW	$	10,565

Cash Flows

The following table presents the major components of the unaudited condensed consolidated statements of cash flows:

	Nine Months Ended
	March 31,						Increase
	2014			2013			(Decrease)
	(In thousands)
Net cash provided by (used in) operating activities	$	1,099		$	(3,116	)	$	4,215
Net cash used in investing activities		(417	)		(507	)		(90	)
Net cash used in financing activities		(48	)		(597	)		(549	)

Operating Activities

The increase in net cash provided by operating activities was primarily due to (i) a decrease in inventories as a result of efforts to bring inventory levels in line with customer demand and (ii) an increase in accounts payable due to the timing of payments to vendors. This increase in net cash from operating activities was partially offset by an increase in accounts receivable during the nine months ended March 31, 2014 as a result of the timing of shipments and collections from customers. During the nine months ended March 31, 2013, cash was used to increase inventory levels and related buffer stock in order to fulfill customer demand as a result of the historically low inventory balance as of June 2012.

Investing Activities

Cash used in investing activities was related to capital expenditures for the purchase of property and equipment, primarily related to tooling and test equipment for new product deployment.

Financing Activities

The decrease in net cash used in financing activities was primarily related to the decrease in payments on the term loan, which was paid off in September 2013, and lower payments on our capital lease obligations as certain of our capital leases expired during the current year period. Additionally, during the nine months ended March 31, 2014, we received $154,000 in proceeds from stock option exercises and the sale of our common stock to participants in our employee stock purchase plan.

Off-Balance Sheet Arrangements

As part of our ongoing business, we have not participated in transactions that generate material relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities (“SPEs”), which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of March 31, 2014, we have not been involved in any material unconsolidated SPEs.

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

As a smaller reporting company, we are not required to provide the information required by this Item 3.

Item 4.

Controls and Procedures

(a) Evaluation of disclosure controls and procedures

We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures. The design of any disclosure controls and procedures also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired objectives.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Report. Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2014 in ensuring that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, to allow timely decisions regarding required disclosure.

(b) Changes in internal controls over financial reporting

There have been no changes in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) identified during the three and nine months ended March 31, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

Reference is made to our Annual Report on Form 10-K for the fiscal year ended June 30, 2013 (the “Form 10-K”) for a description of our legal proceedings. There have been no material changes to the Company’s legal proceedings as disclosed in the Form 10-K.

Item 1A.

Risk Factors

For a discussion of our potential risks and uncertainties, please see the information listed in the item captioned “Risk Factors” in the Form 10-K. There have been no material changes to the risk factors as disclosed in the Form 10-K.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

None.

Item 5.

Other Information

None.

Item 6.

Exhibits

The exhibits listed on the accompanying index to exhibits immediately preceding the exhibits are filed as part of, or hereby incorporated by reference into, this Report.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	LANTRONIX, INC. (Registrant)

Date: May 1, 2014	By:	/s/ KURT BUSCH
		Kurt Busch
		President and Chief Executive Officer
		(Principal Executive Officer)


Date: May 1, 2014	By:	/s/ JEREMY WHITAKER
		Jeremy Whitaker Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

Exhibit Index

The exhibits listed below are hereby filed with the SEC as part of this Quarterly Report on Form 10-Q.

		Incorporated by Reference
Exhibit	Description	Filed Herewith	Form	Exhibit	Filing Date

31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14 and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended	X

31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14 and Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended	X

32.1*	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	X

101	The following financial information from the Company’s Quarterly Report on Form 10-Q, for the period ended December 31, 2013 formatted in XBRL (eXtensible Business Reporting Language): (i) 101.INS BURL Instance Document; (ii) 101.SCH XBRL Taxonomy Extension Schema Document; (iii) 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document; (iv) 101.DEF XBRL Taxonomy Extension Definition Linkbase Document; (v) 101.LAB XBRL Taxonomy Extension Label Linkbase Document; (vi) 101.PRE XBRL Taxonomy Extension Presentation Linkbase Document.	X

______________

Furnished, not filed.